Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624000844549
Ethics application status
Approved
Date submitted
14/05/2024
Date registered
8/07/2024
Date last updated
8/07/2024
Date data sharing statement initially provided
8/07/2024
Type of registration
Retrospectively registered
Titles & IDs
Public title
The Effects of a Three-week Exercises Program in Patients with Diabetic Polyneuropathy: Randomized Controlled Trial
Query!
Scientific title
The Effects of a Supervised Three-week Exercises Program on Range of Motion and Muscle Strength in Lower Leg and Foot, Gait Parameters, Distribution of Pressure and Force on the Ground During Walking and Sensation in Patients with Diabetic Polyneuropathy: Randomized, Two arm, Parallel, Open Label, Controlled Trial
Query!
Secondary ID [1]
312148
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1307-8771
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Diabetic polyneuropathy
333793
0
Query!
Condition category
Condition code
Metabolic and Endocrine
330464
330464
0
0
Query!
Diabetes
Query!
Physical Medicine / Rehabilitation
330465
330465
0
0
Query!
Physiotherapy
Query!
Neurological
330831
330831
0
0
Query!
Other neurological disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Brief name: Exercise program
Patients in the intervention group received alpha-lipoic acid intravenously at a dose of 600 mg dissolved in 250 ml of 0.9% sodium chloride solution, administered over 60 minutes once a day for 15 consecutive therapy days, excluding weekends.
Additionally, they participated in a 50–60-minute daily exercise program for 15 consecutive therapy days, excluding weekends.
The intervention comprised a specific one-on-one kinesiotherapy program consisting of four exercise blocks, each targeting different objectives: (a) increasing foot and ankle range of motion, (b) strengthening foot and ankle muscles, (c) performing functional (balance) exercises and (d) training walking skills and foot rollover.
Each session was composed of some of the exercises from the four exercise blocks.
Gradual and progressive difficulty is offered to the patient, respecting any limitation due to pain and/or decrease in performance during execution. In addition, in each session, the exercises were performed following an order that starts with the passive exercises, progresses to active, and finishes with walking and functional skills.
The exercises were individually adjusted to each patient, guided and supervised by a physiotherapist.
The intensity and speed of performing the exercises are adjusted to prevent pain and discomfort during execution. Each exercise was performed for a specified number of repetitions as described below.
After the 15 days program patients were advised to continue with the learned exercises during the next 6 months and no other advice or restrictions were provided.
Attendance at exercises and all notes are kept in a diary for each patient individually. During follow-up sessions, a questionnaire was filled out regarding how often exercises were performed at home (yes, no, how many times per week).
Range of motion improvement exercises:
- Passive stretching of the flexors and extensors of the toes and hallux was performed from a long sitting position, with knees extended and ankles in a neutral position. Flexion and extension of the toes and hallux are performed separately. Each stretching exercise is repeated 5 times, with each repetition held for 30 seconds.
- The self-stretching of the triceps surae was performed standing, with the contralateral limb positioned ahead, knee bent, and the ipsilateral limb positioned behind, with the foot facing forward. Each exercise position was repeated 5 times, with each repetition held for 30 seconds.
Approximate duration: 15-20 minutes.
Strengthening foot and ankle muscles exercises:
Muscle strengthening exercises for the toes' flexor muscles were performed from a supine lying position using manual resistance. Additionally, exercises for the intrinsic muscles of the foot involved sitting with the foot flat on the floor, gripping an object with the toes.
To strengthen the toes' extensor muscles, exercises were done from a supine lying position with manual resistance and from a sitting position with the foot flat, focusing on toe extension without allowing dorsiflexion.
Exercises for the flexors, extensors, invertors, and evertors of the foot and ankle were performed from a supine lying position using manual resistance. Standing on heels and toes was also included, performed for 1 set of 30 repetitions, except for standing on heels and toes which was done for 1 set of 20 repetitions.
Approximate duration:15 minutes.
Functional (Balance) Training:
- Standing on one leg with or without upper limb support, based on patient tolerance, performed 5 times for 30 seconds on each side.
- Standing on a rubber disc filled with air with support from both legs, performed 5 times for 30 seconds.
- Standing on heels and toes, performed 5 times for 30 seconds.
Balance training started with eyes open and progressed to eyes closed.
Approximate duration: 7 minutes.
Gait training:
- Walking over the heels, toes, lateral border, and medial border of feet at preferred speed.
- Walking in tandem.
- Walking with softening of heel and forefoot contact during normal walking.
- Walking while actively grabbing the floor with toes.
- Walking with normal foot rollover: heel strike, midfoot contact, lateral forefoot, medial forefoot, and hallux contact.
Execution: All walking tasks performed in a straight line at preferred speed for 60 meters each.
Approximate Duration: 10-15 minutes.
Query!
Intervention code [1]
328580
0
Treatment: Other
Query!
Intervention code [2]
328581
0
Rehabilitation
Query!
Comparator / control treatment
The patients in the control group received alpha-lipoic acid intravenously at a dose of 600 mg dissolved in 250 ml of 0.9% sodium chloride solution, administered over 60 minutes once a day for 15 consecutive therapy days, excluding weekends.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
338232
0
Any change in range of motion (ROM) in ankle joint.
Query!
Assessment method [1]
338232
0
ROM measurements for the ankle joint were conducted while the patient was in a supine position using a goniometer. Measurements were taken on the dominant lower limb.
Query!
Timepoint [1]
338232
0
Day 15 (primary outcome effect), 3 months and 6 months from baseline
Query!
Primary outcome [2]
338233
0
Any change in range of motion (ROM) in subtalar joint.
Query!
Assessment method [2]
338233
0
ROM measurements for the subtalar joint were conducted while the patient was in a prone position using a goniometer. Measurements were taken on the dominant lower limb.
Query!
Timepoint [2]
338233
0
Day 15 (primary outcome effect), 3 months and 6 months from baseline
Query!
Primary outcome [3]
338609
0
Any change in range of motion (ROM) in first metatarsophalangeal joint.
Query!
Assessment method [3]
338609
0
ROM measurements for the first metatarsophalangeal joint were conducted while the patient was in a supine position using a goniometer. Measurements were taken on the dominant lower limb
Query!
Timepoint [3]
338609
0
Day 15 (primary outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [1]
436595
0
Change in foot flexors muscle strength (Primary Outcome 4)
Query!
Assessment method [1]
436595
0
Foot flexors muscle strength assessment was conducted using a hand-held dynamometer on the dominant leg while the patient was in a supine position
Query!
Timepoint [1]
436595
0
Day 15 (primary outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [2]
436596
0
Change in foot extensors muscle strength (Primary Outcome 5)
Query!
Assessment method [2]
436596
0
Foot extensors muscle strength assessment was conducted using a hand-held dynamometer on the dominant leg while the patient was in a prone position.
Query!
Timepoint [2]
436596
0
Day 15 (primary outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [3]
436597
0
Change in muscle strength of lower leg and foot muscles (Primary Outcome 6)
Query!
Assessment method [3]
436597
0
Muscle strength assessment of the foot and ankle was conducted manual muscle testing on the dominant leg.
Query!
Timepoint [3]
436597
0
Day 15 (primary outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [4]
436598
0
Sensation of hot
Query!
Assessment method [4]
436598
0
Quantitative sensory testing will provide insight into the function of sensation of hot and cold. The examination will be performed using the PATHWAY Pain and Sensory Evaluation apparatus (MEDOC) utilizing the Limits Cold and Warm Sensation program to detect the threshold of hot sensation in the S1 dermatome on dominant leg.
Query!
Timepoint [4]
436598
0
Day 15 (outcome effect), 3 months and 6 months from baseline.
Query!
Secondary outcome [5]
436599
0
Sensation of cold
Query!
Assessment method [5]
436599
0
Quantitative sensory testing will provide insight into the function of sensation of hot and cold. The examination will be performed using the PATHWAY Pain and Sensory Evaluation apparatus (MEDOC) utilizing the Limits Cold and Warm Sensation program to detect the threshold of cold sensation in the S1 dermatome on dominant leg.
Query!
Timepoint [5]
436599
0
Day 15 (outcome effect), 3 months and 6 months from baseline.
Query!
Secondary outcome [6]
436600
0
Gait performance - composite secondary outcome
Query!
Assessment method [6]
436600
0
The spatiotemporal gait parameters to be measured on the Zebris system are: 1) walking speed (km/h); 2) cadence (number of steps per minute); 3) step width (distance between right and left foot in mm), 4) step length (distance between heel contact of one foot and heel contact of contralateral foot in cm), 5) duration of step (s), 6) stride length (distance between two consecutive heel contacts of one foot in cm), 7) duration of stride (s), 8) stance phase (% of gait cycle, % GC) with three sub-phases: initial double support phase (load response), single limb support phase (mid stance), terminal double support phase (pre-swing), and 9) swing phase (% GC).
Values of these parameters are obtained for both legs.
Query!
Timepoint [6]
436600
0
Day 15 (outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [7]
436601
0
Parameters of dynamic pressure distribution - composite secondary outcome
Query!
Assessment method [7]
436601
0
Parameters of dynamic pressure distribution to be measured on the Zebris system are: 1) length of the gait line, 2) single limb stance phase, 3) antero-posterior position, 4) antero-posterior variability, 5) lateral shift, 6) lateral deviation, 7) contact time, 8) maximum force, 9) time of maximum force, 10) maximum pressure, 11) time of load transfer.
Query!
Timepoint [7]
436601
0
Day 15 (outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [8]
436602
0
Contact time
Query!
Assessment method [8]
436602
0
Contact time is a relative value indicating the percentage of the total duration of the stance phase during which each of the three foot zones (forefoot, midfoot, and hindfoot) was individually in contact with the ground and will be measured on the Zebris system.
Query!
Timepoint [8]
436602
0
Day 15 (outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [9]
436603
0
Maximum force – composite secondary outcome
Query!
Assessment method [9]
436603
0
Maximum force generated during walking is expressed in N/cm² and will be determined separately for the posterior, middle, and anterior parts of the foot bilaterally using Zebris system
Query!
Timepoint [9]
436603
0
Day 15 (outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [10]
436604
0
Time of maximum force - composite secondary outcome
Query!
Assessment method [10]
436604
0
Time of maximum force is a relative value indicating the percentage of the total duration of the stance phase during which maximum force values were achieved in each of the three foot zones (forefoot, midfoot, and hindfoot) and will be measured on the Zebris system.
Query!
Timepoint [10]
436604
0
Day 15 (outcome effect), 3 months and 6 months from baseline
Query!
Secondary outcome [11]
436605
0
Maximum pressure - composite secondary outcome
Query!
Assessment method [11]
436605
0
Maximum pressure exerted by the foot on the ground during walking is expressed in N/cm² and will be determined separately for the posterior, middle, and anterior parts of the foot bilaterally using Zebris system.
Query!
Timepoint [11]
436605
0
Day 15 (outcome effect), 3 months and 6 months from baseline
Query!
Eligibility
Key inclusion criteria
Inclusion criteria were as follows: age between 40 to 65 years, diabetes mellitus type 1 or 2 diagnosed for at least five years, stable glycemic control, body mass index ranging between 18,5 and 29,9 kg/m2 (normal and overweight), electroneurographic findings indicating presence of the diabetic neuropathy and ability to walk independently, without any device.
Query!
Minimum age
40
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Unstable glycemic control, active diabetic foot ulcer, amputation, central neurological impairments, any other peripheral neurological impairments except diabetic polyneuropathy, orthopedic disease or previous surgery, rheumatology disease affecting movement, severe vestibular and ocular impairments that affect movement, severe nephropathy or diabetic polyneuropathy, presence of unresolved aetiology pain, intermittent claudication, ankle-brachial index value less than 0.8 or greater than 1.2 and presence of malignant disease.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sealed opaque envelopes
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A total of 90 sealed envelopes (45 with intervention and 45 with control group) was used for simple randomization of participants.
To ensure random allocation, an equal number of papers indicating group allocation were counted twice. These papers were then placed into envelopes, each securely sealed and checked to ensure the glue covered the entire surface. The envelopes were then mixed thoroughly on a table for several minutes. After mixing, each envelope was inspected again for any signs of tampering or detachment. Subsequently, the mixed envelopes were placed into a designated enrollment box.
When new participants met the enrollment criteria, envelopes were randomly drawn from the box for assignment. Opened envelopes were segregated into a separate container to prevent mixing with unopened ones. Upon opening the final envelope, all envelopes were meticulously counted and inspected for any discrepancies.
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Sample size calculation is based on difference between two means in independent samples t test. A sample size of 40 per group is sufficient to achieve 80% power to detect significant difference of 3.7 degrees change in ankle joint range of motion, between intervention and control group. Same sample size has 99% power to detect significant difference of muscle strenght change between groups.
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
16/07/2021
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
19/09/2022
Query!
Date of last data collection
Anticipated
Query!
Actual
3/04/2023
Query!
Sample size
Target
90
Query!
Accrual to date
Query!
Final
82
Query!
Recruitment outside Australia
Country [1]
26306
0
Bosnia and Herzegovina
Query!
State/province [1]
26306
0
Republika Srpska
Query!
Funding & Sponsors
Funding source category [1]
316509
0
Hospital
Query!
Name [1]
316509
0
Institute for Physical Medicine, Rehabilitation and Orthopedic Surgery “Dr Miroslav Zotovic” Banja Luka
Query!
Address [1]
316509
0
Query!
Country [1]
316509
0
Bosnia and Herzegovina
Query!
Primary sponsor type
Hospital
Query!
Name
Institute for Physical Medicine, Rehabilitation and Orthopedic Surgery “Dr Miroslav Zotovic” Banja Luka
Query!
Address
Query!
Country
Bosnia and Herzegovina
Query!
Secondary sponsor category [1]
318688
0
None
Query!
Name [1]
318688
0
Query!
Address [1]
318688
0
Query!
Country [1]
318688
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
315305
0
Ethics Committee of the Institute “Dr Miroslav Zotovic”
Query!
Ethics committee address [1]
315305
0
Institute for Physical Medicine, Rehabilitation and Orthopedic Surgery "Dr Miroslav Zotovic" Banja Luka; Slatinska Street No 11; Banja Luka, Postcode 78000; Republika Srpska, Bosnia and Herzegovina
Query!
Ethics committee country [1]
315305
0
Bosnia and Herzegovina
Query!
Date submitted for ethics approval [1]
315305
0
24/02/2020
Query!
Approval date [1]
315305
0
05/03/2020
Query!
Ethics approval number [1]
315305
0
116-21-3090-1/20
Query!
Ethics committee name [2]
315307
0
Ethics Committee Faculty of Medicine, University of Banja Luka
Query!
Ethics committee address [2]
315307
0
Save Mrkalja 14, Banja Luka 78000, Bosna i Hercegovina, +387 51 234 100
Query!
Ethics committee country [2]
315307
0
Bosnia and Herzegovina
Query!
Date submitted for ethics approval [2]
315307
0
01/02/2020
Query!
Approval date [2]
315307
0
02/03/2020
Query!
Ethics approval number [2]
315307
0
18/4.3.13/20
Query!
Summary
Brief summary
There is significant evidence supporting the effectiveness of foot-related exercise programs when combined with health-promoting interventions in improving neuropathy signs and symptoms, enhancing gait, restoring foot and ankle joint mobility, redistributing pressure during walking, and increasing foot strength and function. These combined efforts can help mitigate risk factors for diabetic foot ulcers. Considering that diabetic polyneuropathy is a chronic condition, with complications in muscles and joints developing over the long term, preserving and maintaining their integrity is of paramount importance. It is expected that specific interventions could lead to the recovery of muscle and joint function in patients with diabetic polyneuropathy. The objective of this study is to determine the effect of supervised stretching, strengthening, functional, and walking exercises on joint mobility and muscle strength in patients with diabetic polyneuropathy.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
134282
0
Dr Snježana Novakovic Bursac
Query!
Address
134282
0
Institute for Physical Medicine, Rehabilitation and Orthopedic Surgery "Dr Miroslav Zotovic" Banja Luka/Slatinska Street No 11/City: Banja Luka/Postcode: 78000/State: Republika Srpska,
Query!
Country
134282
0
Bosnia and Herzegovina
Query!
Phone
134282
0
+387 65 618789
Query!
Fax
134282
0
Query!
Email
134282
0
[email protected]
Query!
Contact person for public queries
Name
134283
0
Snježana Novakovic Bursac
Query!
Address
134283
0
Institute for Physical Medicine, Rehabilitation and Orthopedic Surgery "Dr Miroslav Zotovic" Banja Luka/Slatinska Street No 11/City: Banja Luka/Postcode: 78000/State: Republika Srpska,
Query!
Country
134283
0
Bosnia and Herzegovina
Query!
Phone
134283
0
+387 65 618789
Query!
Fax
134283
0
Query!
Email
134283
0
[email protected]
Query!
Contact person for scientific queries
Name
134284
0
Snježana Novakovic Bursac
Query!
Address
134284
0
Institute for Physical Medicine, Rehabilitation and Orthopedic Surgery "Dr Miroslav Zotovic" Banja Luka/Slatinska Street No 11/City: Banja Luka/Postcode: 78000/State: Republika Srpska,
Query!
Country
134284
0
Bosnia and Herzegovina
Query!
Phone
134284
0
+387 65 618789
Query!
Fax
134284
0
Query!
Email
134284
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
The individual data of participants are not essential for the results of the study. During the process of obtaining consent for participation in the study, we committed to ensuring that the data of individual participants in the study would remain protected
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF